Cargando...
Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment
OBJECTIVE: To evaluate the efficacy and safety of minocycline in the management of HIV-associated cognitive impairment. METHODS: We enrolled HIV-positive participants with a CD4 count of 250 to 500 cells/μL in a randomized, double-blind, placebo-controlled study. They received 100 mg of minocycline...
Gardado en:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Lippincott Williams & Wilkins
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3589188/ https://ncbi.nlm.nih.gov/pubmed/23269596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e31827b9121 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|